Peter Benedict

Executive

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 1 saleJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 1 saleApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€124k

Latest filing published 27 Jul 2026 for Usana Health Sciences INC. Read the official filing

Filing timeline

BuySale

Peter Benedict

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Peter Benedict: trading record in brief

Peter Benedict appears in our data through filings on Usana Health Sciences Inc shares, published by SEC (Form 4). Over a trading history stretching from 6 February 2025 to 25 July 2026, the count stands at 9 filings.

Every open-market trade on record is a sale: 2 sales worth €124k. Besides market trades, the filings include 1 share grant and 6 option exercises. Since January 2026: no purchases and 1 sale on the market.

On 27 July 2026 came the latest disclosure, an option exercise in Usana Health Sciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.